EDESA BIOTECH, INC. Preferred Stock, Value, Issued
EDESA BIOTECH, INC. (EDSA) had Preferred Stock, Value, Issued of $981.17 thousand as of 2024-12-31, per its 10-Q filed 2025-02-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2025-02-14
- 2024-12-31: Preferred Stock, Value, Issued $981.17K.
- 2024-09-30: Preferred Stock, Value, Issued $0.00.
- 2021-09-30: Preferred Stock, Value, Issued $0.00.
- 2021-06-30: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2024-12-31 | $981.17K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $0.00 10-Q · filed 2025-02-14 |
| 2021-09-30 | $0.00 10-K · filed 2021-12-28 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.37M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $2.48M 10-K · filed 2021-12-28 |
| 2020-06-30 | $2.46M 10-Q · filed 2020-08-12 |
| 2019-09-30 | $0.00 10-K · filed 2020-12-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2018-12-31 | $6.06M 10-KT · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |